CS
Colin Shannon
President & CEODirector

Colin Shannon insider trades: PRA Health Sciences (PRAH) stock sales

President & CEO, PRA Health Sciences Last trade Jun 17, 2021 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2005
3
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Colin reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 17, 2021PRAH↓ Sell$74.6M
Jun 16, 2021PRAH↓ Sell$38.8M
Jun 1, 2021PRAH↓ Sell$1.1M
Aug 13, 2020PRAH↓ Sell$625K
Aug 14, 2017PRAH↓ Sell$29.9M
Mar 28, 2017PRAH↓ Sell$3.2M
Feb 23, 2017PRAH↓ Sell$6.2M
Aug 22, 2016PRAH↓ Sell$5.8M
Mar 8, 2016PRAH↓ Sell$3.3M
May 4, 2007PPDI↓ Sell$340K
Feb 9, 2007PPDI↓ Sell$1.1M
Oct 20, 2006PPDI↓ Sell$2.5M
Jul 20, 2005PPDI↓ Sell$2.1M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Colin Shannon's insider trades

Colin Shannon is President & CEO at PRA Health Sciences (PRAH). Since Jul 20, 2005, Colin has reported no open-market purchases and 13 sales worth $169.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (12 filings), grants and awards (7 filings), shares returned to the company (2 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRAH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.